Skip to content

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859359
Acronym
IMPACT-HDP
Enrollment
1200
Registered
2025-03-05
Start date
2024-08-08
Completion date
2029-06-01
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Disorder of Pregnancy

Keywords

Hypertension, Pregnancy, Preeclampsia, HDP

Brief summary

The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?

Detailed description

This study aims to contextualize, implement, and evaluate the feasibility, fidelity, and acceptability and effectiveness of: 1) postpartum remote blood pressure monitoring, 2) patient education, 3) development of a standardized postpartum follow-up protocol, and 4) provision of free and/or subsidized antihypertensive medications for patients with HDP in University of Abuja, Murtala Muhammad Specialist Hospital, National Hospital, Abuja and Aminu Kano Teaching Hospital all in Nigeria. These components collectively make up a contextualized postpartum BP monitoring program called the HDP Implementation Bundle. The long-term objective is to implement a contextualized and acceptable evidence-based postpartum home BP monitoring program with supporting services and components, at 4 tertiary care institutions in Nigeria, to improve postpartum BP control in patients with HDP using a multilevel approach.

Interventions

OTHERHypertension Disorders of Pregnancy (HDP) Implementation Bundle

The HDP Implementation Bundle will consist of 4 main blocks namely; patient education, home BP monitoring, a contextualized follow-up protocol and provision of free anti-hypertensives if need. Collectively, these will lead to design and development of a contextualized home BP monitoring program.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Type 1 hybrid stepped-wedge cluster randomized trial to assess if the utilization of the HDP Implementation Bundle will improve postpartum BP among women with HDP in Nigeria. Randomization will be done at cluster level and sites will begin in control and cross over to intervention phase

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Postpartum adults (\>18 years) * postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services) * with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent.

Exclusion criteria

* unable to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Between group difference in change in systolic BP from baseline to 6-week follow-upBaseline to 6 weeksThe change in systolic BP from baseline to 6-week follow-up between the intervention and control group

Secondary

MeasureTime frameDescription
Between group differences in change in diastolic BP at 6 weeks follow-up and change in both systolic an diastolic BP at 12 weeksBaseline to 6(and 12) weeksThe change in diastolic BP from baseline to 6-week follow-up between the intervention and control groups.
Between group differences in systolic and diastolic BP at 12 weeks follow-upBaseline to 12 weeksThe change mean systolic and diastolic BPs 12 weeks follow-up between the intervention and control group

Countries

Nigeria

Contacts

CONTACTDike Ojji, MBBS, PhD
dike.ojji@uniabuja.edu.ng+234-806-009-4456
CONTACTKamilu Karaye, MBBS, PhD
kkaraye@yahoo.co.uk+2348037042171
PRINCIPAL_INVESTIGATORZainab Mahmoud, MD, MSc

Washington University School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026